[size=0.938]RETURN TO ARTICLES ASAP[size=0.938]PREVARTICLE[size=0.938]NEXT
Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors- Junwei Wang
- ,
- Quanjin Rong
- ,
- Lei Ye
- ,
- Bingqian Fang
- ,
- Yifan Zhao
- ,
- Yu Sun
- ,
- Haikun Zhou
- ,
- Dan Wang
- ,
- Jinting He
- ,
- Zhenzhen Cui
- ,
- Qijian Zhang
- ,
- Di Kang*
- , and
- Lihong Hu*
[size=0.75]Cite this: J. Med. Chem. 2024, XXXX, XXX, XXX-XXX
Publication Date:April 24, 2024[size=0.75][/url]
[url=https://doi.org/10.1021/acs.jmedchem.4c00051]https://doi.org/10.1021/acs.jmedchem.4c00051
|
10
Palladium-Catalyzed Asymmetric Hydroesterification of ¦Á-Aryl Acrylic Acids to Chiral Substituted Succinates
